Share on LinkedInShare on LinkedIn

ARTICLE · 17 SEPTEMBER 2020

How Is Coronavirus Affecting Clinical Trials And Future Innovation In The UK?

A recent analysis by the University of Southampton has shown the devastating effect of the coronavirus (COVID-19) pandemic on the early stage research space through the suspension of over 9,000...

United KingdomCoronavirus (COVID-19)

A recent analysis by the University of Southampton has shown the devastating effect of the coronavirus (COVID-19) pandemic on the early stage research space through the suspension of over 9,000, and cancelling of over 1,000, clinical trials in the UK.

To ensure hospital visits were kept extremely limited and for urgent care only during the height of the pandemic, the UK regulator, the Medicines and Healthcare products Regulatory Agency, called for the suspension of certain clinical trials due to the risk of drug shortages and risk of infection, particularly of patients considered vulnerable due to pre-existing conditions.

There was also an urgent need to focus on prioritising trials connected with the prevention or 'cure' of coronavirus; as a result, these trials took precedence, whilst others faded further into the background.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from